TELETRADER News
2/17, 1:43 PM (Source: TeleTrader)
more TeleTrader news

Merck-0.65%

184.55
Chart for: MERCK KGAA O.N.

South Africa authorizes Merck's COVID drug

South Africa's health authorities announced on Thursday the government has approved the use of Merck's COVID-19 treatment known as molnupiravir.

The South African Health Products Regulatory Authority (SAHPRA) noted that "the authorization of molnupiravir for compassionate use offers further therapy in the fight against COVID-19."

The drug has been approved in the United States for treating mild-to-moderate COVID-19 symptoms since December.

Baha Breaking News (BBN) / ND